Sanjay Shrivastava - 30 Nov 2022 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Director
Signature
/s/ Sanjay Shrivastava.
Issuer symbol
NVNO
Transactions as of
30 Nov 2022
Transactions value $
$0
Form type
4
Filing time
02 Dec 2022, 15:30:37
Previous filing
01 Jul 2022
Next filing
07 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVNO Stock Options Award $0 +8.4K $0.00 8.4K 30 Nov 2022 Common Stock 8.4K $6.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year.